Learn more about Abbott's line of Freestyle Libre continuous glucose monitors (CGMs).
Dexcom
+6
/
Sep 10, 2025
The top continuous glucose monitors are set to get new features. From longer wear times, to multiple measured analytes, here’s what’s next in CGM innovation.
Medtronic
+5
Sep 2, 2025
Medtronic's SmartGuard algorithm is cleared for the upcoming 15-day Instinct CGM and the MiniMed 780G gets clearance for type 2 diabetes.
+3
Aug 11, 2025
Medtronic's new CGM built by Abbott is 510(k) pending and under FDA review, signaling major changes ahead for MiniMed insulin pumps.
News
+4
Jul 8, 2025
From tubeless pumps to a dual glucose-ketone sensor and cell therapy breakthroughs—ADA 2025 delivered game-changing updates in diabetes tech. Here's what stood out.
Jun 20, 2025
Abbott’s flagship CGM now powers Tandem’s Control-IQ+ system—with more pump integrations and a ketone sensor on the horizon.
CGM
+7
Tandem, Beta Bionics, Sequel Med Tech, and Ypsomed are the first to announce integration plans for Abbott’s dual-analyte sensor with more expected.
Jun 12, 2025
The next wave of continuous glucose monitors promises better accuracy, longer wear time and more insulin pump integrations.
Apr 21, 2025
Abbott's new app brings much needed upgrades like silence Low Alarms and control of all sensors under one umbrella.
